1.0Alliance for Immunology Innovations (AII)https://eutranslationalmedicine.org/aiiadminhttps://eutranslationalmedicine.org/aii/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="PmWp0fC3kl"><a href="https://eutranslationalmedicine.org/aii/autoimmune-diseases-2/">Autoimmune Diseases</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://eutranslationalmedicine.org/aii/autoimmune-diseases-2/embed/#?secret=PmWp0fC3kl" width="600" height="338" title="“Autoimmune Diseases” — Alliance for Immunology Innovations (AII)" data-secret="PmWp0fC3kl" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://eutranslationalmedicine.org/aii/wp-includes/js/wp-embed.min.js </script> Autoimmune diseases affect millions worldwide, driven by complex interactions between genetics, immune dysregulation, and environmental triggers. Biopharmaceutical companies are pioneering targeted therapies to suppress or reprogram harmful immune responses while preserving healthy immune function. These innovations aim to improve outcomes in chronic, often debilitating conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel […]